title: Management of recalcitrant hidradenitis suppurativa with ustekinumab.
authors.forename: Victoria R
authors.initials: VR
authors.lastname: Sharon
authors.forename: Miki Shirakawa
authors.initials: MS
authors.lastname: Garcia
authors.forename: Sepideh
authors.initials: S
authors.lastname: Bagheri
authors.forename: Heidi
authors.initials: H
authors.lastname: Goodarzi
authors.forename: Clara
authors.initials: C
authors.lastname: Yang
authors.forename: Yoko
authors.initials: Y
authors.lastname: Ono
authors.forename: Emanual
authors.initials: E
authors.lastname: Maverakis
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D004351:Drug Resistance; D017497:Hidradenitis Suppurativa / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy; D000069549:Ustekinumab
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069549:Ustekinumab